Product Information
RIFAMPIN 300 MG CAPSULE is a generic product labeled by Major Pharmaceuticals, priced at $0.6802 per EA under NDC 00904731561. Its NADAC has been published 61 times since Jun 25, 2025.
FDA first approved this application on Aug 21, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
300 mg/1
Manufacturer
Major PharmaceuticalsNDC
00904731561
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
RIFAMPINApproval Type
Generic (ANDA)
FDA Application
ANDA090034FDA Approved
8/21/2013
TE Code
AB
On Market Since
2/25/2025
Pharmacological Classes
Price Statistics
The NADAC for RIFAMPIN 300 MG CAPSULE has been published 61 times since Jun 25, 2025, and over the history we have for it it has declined 6.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6802 per EA |
|---|---|
| All-time high | $0.7246 (Jul 16, 2025) |
| All-time low | $0.6802 (Aug 19, 2026) |
| 52-week high | $0.7186 |
| 52-week low | $0.6802 |
| Median price | $0.6921 |
| Average price | $0.6984 |
| Largest weekly change | -2.3% (Nov 19, 2025) |
| Weeks tracked | 61 |
| Tracking since | Jun 25, 2025 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of RIFAMPIN 300 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for RIFAMPIN 300 MG CAPSULE, manufactured by Major Pharmaceuticals, is $0.6802 per EA (NDC 00904731561), effective Aug 19, 2026.
How has the price of RIFAMPIN 300 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for RIFAMPIN 300 MG CAPSULE has declined 6.1%. It has been tracked across 61 weekly CMS publications since Jun 25, 2025.
What are the highest and lowest recorded NADAC prices for RIFAMPIN 300 MG CAPSULE?
Since Jun 25, 2025, the NADAC for RIFAMPIN 300 MG CAPSULE has ranged from a low of $0.6802 (Aug 19, 2026) to a high of $0.7246 (Jul 16, 2025), with a median of $0.6921 per EA.
Are there cheaper alternatives to RIFAMPIN 300 MG CAPSULE?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as RIFAMPIN 300 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures RIFAMPIN 300 MG CAPSULE?
RIFAMPIN 300 MG CAPSULE (NDC 00904731561) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.